关注
Mohammad Amin Hemmati
Mohammad Amin Hemmati
Student Research Committee, Semnan University of Medical Sciences, Semnan, Iran
在 semums.ac.ir 的电子邮件经过验证
标题
引用次数
引用次数
年份
Sodium glucose Cotransporter-2 inhibitor Empagliflozin increases antioxidative capacity and improves renal function in Diabetic rats
H Yaribeygi, MA Hemmati, F Nasimi, M Maleki, T Jamialahmadi, I Reiner, ...
Journal of Clinical Medicine 12 (11), 3815, 2023
112023
Empagliflozin alleviates diabetes-induced cognitive impairments by lowering nicotinamide adenine dinucleotide phosphate oxidase-4 expression and potentiating the antioxidant …
H Yaribeygi, MA Hemmati, F Nasimi, R Pakdel, T Jamialahmadi, ...
Behavioural Brain Research 460, 114830, 2024
52024
Using new technologies to analyze gut microbiota and predict cancer risk
MA Hemmati, M Monemi, S Asli, S Mohammadi, B Foroozanmehr, ...
Cells 13 (23), 1987, 2024
42024
Modulating effects of crocin on lipids and lipoproteins: Mechanisms and potential benefits
H Yaribeygi, M Maleki, F Rashid-Farrokhi, PR Abdullahi, MA Hemmati, ...
Heliyon, 2024
42024
Innovative Antibiotic Therapies for Carbapenem-Resistant Gram-Negative Bacterial Infections: Clinical Efficacy, Safety, and Comparative Studies
M Eslami, A Safaripour, SZ Banihashemian, S Nikjoo Niaragh, ...
Microorganisms 13 (2), 295, 2025
2025
Sodium-glucose cotransporter 2 inhibitors and renin-angiotensin-aldosterone system, possible cellular interactions and benefits
B Forouzanmehr, AH Hedayati, E Gholami, MA Hemmati, M Maleki, ...
Cellular Signalling 122, 111335, 2024
2024
GLP-1 mimetics and diabetic ketoacidosis: possible interactions and clinical consequences
B Forouzanmehr, MA Hemmati, SL Atkin, T Jamialahmadi, H Yaribeygi, ...
Naunyn-Schmiedeberg's Archives of Pharmacology, 1-12, 2024
2024
系统目前无法执行此操作,请稍后再试。
文章 1–7